STAAR Surgical Company (STAA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated February 26, 2025, reports significant changes to the executive leadership and Board of Directors of STAAR Surgical Company. The filing details the appointment of a new Chief Executive Officer (CEO), the election of a new Board Chair, and the departure of the former CEO.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes and Leadership Transition
- New CEO: Stephen C. Farrell was appointed President and CEO, effective February 26, 2025. He succeeds Thomas G. Frinzi.
- New Board Chair: Elizabeth Yeu, M.D., was elected Board Chair, effective February 26, 2025.
- Former CEO Departure: Thomas G. Frinzi stepped down as President, CEO, Board Chair, and Board member effective February 26, 2025.
- Board Composition: The Board size was reduced from seven to six members. Lilian Zhou was appointed Chair of the Audit Committee.
Compensation and Transition Arrangements
- Stephen C. Farrell (New CEO):
- Base Salary: $725,000 annually.
- Target Bonus: 100% of base salary.
- Equity: 200,000 Restricted Stock Units (vesting 1/3 annually over 3 years) and 200,000 Performance Stock Units (0-200% target based on revenue performance through Dec 31, 2027).
- Relocation: Up to $250,000 reimbursement for 2025 expenses.
- Thomas G. Frinzi (Former CEO):
- Severance: Eligible for 18 months of base salary upon execution of a separation agreement.
- Consulting Role: Agreed to serve as an advisor through January 26, 2026, at a rate of $45,000 per month.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking financial guidance, risk factors, or discussion of contingencies. The primary focus is the execution of the leadership transition to ensure operational continuity.
Key Facts for Investor Verification
- Verify the vesting conditions and performance targets for Mr. Farrell's 200,000 Performance Stock Units.
- Confirm the total cash severance obligation for Mr. Frinzi based on his final base salary.
- Review the impact of the Board size reduction and committee reassignments on corporate governance.
- Monitor the transition period through January 2026 to assess the effectiveness of the new leadership structure.